1. Notal Vision

    0 Comments Leave a Comment

    1-15 of 33 1 2 3 »
    1. Mentioned In 33 Articles

    2. Notal Vision announces publication of first prospective longitudinal pilot study of daily self-imaging with patient-operated Home OCT in wet AMD patients

      Notal Vision announces publication of first prospective longitudinal pilot study of daily self-imaging with patient-operated Home OCT in wet AMD patients
      ...eration. Ophthalmology Science 2021 (in press), https://doi.org/10.1016/j.xops.2021.100034 About Notal Vision Notal Vision is a diagnostic services company that operates the Notal Vision Diagnostic Clinic, a medical prov...
      Read Full Article
      Mentions: FDA Notal Vision
    3. Notal Vision raises up to $60 million to support development of its Home OCT technology and commercial growth of its ForeseeHome AMD Monitoring Program

      Notal Vision raises up to $60 million to support development of its Home OCT technology and commercial growth of its ForeseeHome AMD Monitoring Program
      ...lize and improve the outcome of existing anti-VEGF therapy and emerging treatment options. About Notal Vision Notal Vision is a diagnostic services company that operates the Notal Vision Diagnostic Clinic, a medical prov...
      Read Full Article
      Mentions: Notal Vision
    4. Current status of home monitoring technology for age-related macular degeneration

      Current status of home monitoring technology for age-related macular degeneration
      Purpose of review Evidence suggests that patients present with exudative age-related macular degeneration (AMD) in a delayed fashion. Increased lesion size associated with this delay directly impacts visual acuity. Upon treatment initiation, patients are monitored largely with optical coherence tomography (OCT) technology to determine the need for treatment. Home-monitoring systems using preferential hyperacuity perimetry (PHP) and OCT may optimize management. Recent findings Comparison of Age-related Macular Degeneration Treatment Trials study ...
      Read Full Article
      Mentions: Notal Vision
    5. Asclepix Therapeutics partners with Notal Vision on Home OCT remote monitoring in DME and AMD clinical trials

      Asclepix Therapeutics partners with Notal Vision on Home OCT remote monitoring in DME and AMD clinical trials
      ... interpretation and documentation of AI-based analyses will be billable every 30 days.  About Notal Vision  Notal Vision is a diagnostic services company that operates the Notal Vision Diagnostic Clinic, a medical prov...
      Read Full Article
      Mentions: FDA Notal Vision
    6. Remote monitoring with Home OCT

      Remote monitoring with Home OCT
      In this video, Anat Loewenstein, MD, MHA, speaks about a Home OCT device. This technology has been tested in studies, and patients have been given the chance to try it at home, following a few, simple instructions. Some of them also speak here. Home monitoring is one of the most promising new frontiers in healthcare, leading to: reduced number of patient visits reduced patient burden increased safety in the time ...
      Read Full Article
      Mentions: Notal Vision
    7. Home OCT with AI analysis may lead to ‘paradigm shift’ in AMD management

      Home OCT with AI analysis may lead to ‘paradigm shift’ in AMD management
      A novel artificial intelligence-based algorithm for automatic retinal fluid quantification in home OCT images performed comparably to human readers, according to a presentation from the virtual American Society of Retina Specialists meeting. This system was able to analyze fluid status, its dynamics and visualize the locations of fluid, Judy E. Kim, MD, professor of ophthalmology and visual sciences at Medical College of Wisconsin, said during the presentation. Currently, much of ...
      Read Full Article
      Mentions: Notal Vision
    8. Retinal specialist versus artificial intelligence detection of retinal fluid from optical coherence tomography: AREDS2 10-year Follow-On

      Retinal specialist versus artificial intelligence detection of retinal fluid from optical coherence tomography: AREDS2 10-year Follow-On
      Purpose To evaluate the performance of retinal specialists in detecting retinal fluid presence in spectral domain optical coherence tomography (SD-OCT) macular volume scans from eyes with age-related macular degeneration (AMD), and to compare performance with the artificial intelligence (AI)-based Notal OCT Analyzer (NOA). Design Prospective comparison of retinal fluid grades from human retinal specialists and the NOA on SD-OCT scans from two commonly used devices (Cirrus and Spectralis). Participants ...
      Read Full Article
    9. 1-15 of 33 1 2 3 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. About Notal Vision

    Notal Vision

    Notal Vision was founded by two ophthalmologists, and is committed to providing the eyecare community with innovative, home-based, technology solutions that support visual health in patients with retinal diseases. The company's ForeseeHome ® device is the first FDA-cleared home telemonitoring device that detects and characterizes visual distortion in AMD patients as an aid to monitoring choroidal neovascularization progression.

  3. Quotes about Notal Vision

    1. Notal Vision has established a seamless, cloud-based infrastructure that connects healthcare providers and their patients through personalized, home-based monitoring designed to facilitate earlier ocular disease detection.
      In Notal Vision Celebrates 3 Millionth ForeseeHome® AMD Home-Monitoring Test